Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193877/?tool=EBI

Similar Items

Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
by: Li-Xu Yan, et al.
Published: (2018-01-01)

Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
Published: (2014-01-01)

MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.
by: Li-Xu Yan, et al.
Published: (2014-01-01)

BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified
by: Mario L. Marques-Piubelli, et al.
Published: (2021-09-01)

The survival impact of combined expression of myc, bcl2 and bcl6 in diffuse large b cell lymphoma patients
by: Adelina BIRCEANU COROBEA, et al.
Published: (2018-06-01)

BCL6 mRNA Expression Level in Invasive Duct Carcinoma not otherwise Specified
by: Eman Badr, et al.
Published: (2016-12-01)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
by: YunXiang Zhang, et al.
Published: (2019-01-01)

Oxidative stress in diffuse large B-cell lymphoma and follicular lymphoma, and TP53 mutations and translocations of MYC, Bcl-2 and Bcl-6 in diffuse large B-cell lymphoma
by: Peroja, P. (Pekka)
Published: (2018)

Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
by: Jonathan Wawire, et al.
Published: (2019-04-01)

Combination of Bcl-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma
by: Wang J, et al.
Published: (2015-09-01)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
by: Sixia Huang, et al.
Published: (2019-07-01)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
by: Weiping Li, et al.
Published: (2019-07-01)

Expression of PD-L1 and Its Clinical Significance in MYC/BCL2 Double-expression Large B Cell Lymphoma
by: WANG Ping, et al.
Published: (2020-01-01)

Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort
by: Bogyeong Han, et al.
Published: (2020-11-01)

High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
by: Cheng-Chih Tsai, et al.
Published: (2021-03-01)

Peripheral T cell lymphoma: Not otherwise specified
by: Anusha H Pai, et al.
Published: (2015-01-01)

Peripheral T-cell lymphoma, not otherwise specified
by: Kunal Kishor Jha, et al.
Published: (2017-01-01)

The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
by: Jisun Hwang, et al.
Published: (2021-07-01)

C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: A study of 97 patients
by: Bahar Akkaya, et al.
Published: (2016-01-01)

Bcl-2 protein in diffuse large B-cell lymphoma
by: Viroj Wiwanitkit
Published: (2011-01-01)

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas
by: Zhenming Cai, et al.
Published: (2020-06-01)

Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.
by: Agata M Bogusz, et al.
Published: (2017-01-01)

Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
by: Mette Ølgod Pedersen, et al.
Published: (2017-01-01)

DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations.
by: Chidimma Agatha Akpa, et al.
Published: (2019-01-01)

Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study
by: Paisarn Boonsakan, et al.
Published: (2020-01-01)

Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma
by: Aydan KILIÇARSLAN, et al.
Published: (2018-09-01)

Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.
by: Hee Young Na, et al.
Published: (2019-01-01)

Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma
by: Kun-Ming Chung, et al.
Published: (2013-07-01)

Chronic Eosinophilic Leukemia—Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma
by: Wilson I. Gonsalves, et al.
Published: (2013-01-01)

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
by: Alison M. Moore, et al.
Published: (2018-05-01)

The Correlation between Prognosis and Expression of CD10, Bcl-6, MUM1 and Bcl-2 in Canine Lymphomas
by: Yao-Chun Chien, et al.
Published: (2013)

Strong BCL2 expression in Burkitt lymphoma is not uncommon in adults
by: Shahid Pervez, et al.
Published: (2011-01-01)

Sarcoidosis-Lymphoma Syndrome Associated with Folliculotropic Peripheral T Cell Lymphoma Not Otherwise Specified
by: Saaya Yoshida, et al.
Published: (2017-04-01)

Expression of B-cell Lymphoma 2 (BCL-2) in Breast Cancer
by: Sehar Bashir, et al.
Published: (2021-01-01)

p53, Bcl-2 and C-Myc Expressions in Colorectal Carcinoma Associated with Schistosomiasis in Egypt
by: Khaled R. Zalata, et al.
Published: (2005-01-01)

Expression of Bcl-2 protein and the amplification of c-myc gene in patients with chronic myeloid leukemia
by: Strnad Milica, et al.
Published: (2006-01-01)

Peripheral T-cell lymphoma-not otherwise specified presenting as disfiguring facial swelling
by: Arghya Bandyopadhyay, et al.
Published: (2021-01-01)

Evaluation of BCL6 and MUM1 Expression in Patients with Diffuse Large B Cell Lymphoma (DLBCL) and Their Correlation with Staging and Prognosis of the Disease
by: Hossein Rahimi, et al.
Published: (2015-01-01)

Bcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma
by: Abrahão Elias Hallack Neto, et al.

Dissecting diffuse large B-cell lymphomas of the “not otherwise specified” type: the impact of molecular techniques [version 1; referees: 2 approved]
by: Stefano A Pileri, et al.
Published: (2018-12-01)